Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Integrated Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10294
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company’s tools assist physicians in the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer by simultaneously monitoring disease molecular markers. It provides product such as Xpresys lung, a molecular blood test to provide non-invasive objective information for the assessment of pulmonary nodules. Indi’s other products include PET scan, bronchoscopy, needle biopsy, and others. It conducts research and development on diagnostics and measurement technologies used for measuring several bio-markers simultaneously for improved diagnosis and accurate management of complex diseases. Indi is headquartered in Seattle, Washington, the US.

Integrated Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Integrated Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Integrated Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Integrated Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Integrated Diagnostics Raises USD6 Million in Series C Financing 10
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 11
Integrated Diagnostics Raises US$30 Million In Series B Financing 12
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 14
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 15
Partnerships 17
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 17
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 18
Acquisition 19
Biodesix Acquires Integrated Diagnostics 19
Integrated Diagnostics Inc – Key Competitors 20
Integrated Diagnostics Inc – Key Employees 21
Integrated Diagnostics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Aug 16, 2018: Integrated Diagnostics Holdings results for the six-month period ended 30 June 2018 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Integrated Diagnostics Inc, Medical Equipment, Key Facts 2
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Integrated Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Integrated Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Integrated Diagnostics Raises USD6 Million in Series C Financing 10
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 11
Integrated Diagnostics Raises US$30 Million In Series B Financing 12
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 14
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 15
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 17
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 18
Biodesix Acquires Integrated Diagnostics 19
Integrated Diagnostics Inc, Key Competitors 20
Integrated Diagnostics Inc, Key Employees 21

List of Figures
Integrated Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Integrated Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Integrated Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avesthagen Ltd-医療機器分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • Ocwen Financial Corporation:企業のM&A・事業提携・投資動向
    Ocwen Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ocwen Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務分析
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Indigo Books & Music, Inc.:戦略・SWOT・企業財務分析
    Indigo Books & Music, Inc. - Strategy, SWOT and Corporate Finance Report Summary Indigo Books & Music, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • K2M Inc-医療機器分野:企業M&A・提携分析
    Summary K2M Inc (K2M), a subsidiary of K2M Group Holdings Inc is a medical device company that designs, develops and markets spine solutions products for the treatment of spinal pathologies. The company offers complex spine, minimally invasive, degenerative and biologics products. It offers complex …
  • Chronos Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Chronos Therapeutics Ltd (Chronos) is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, pipeline development and clinical trial services. Its p …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bank Of Cyprus Public Company Ltd:企業の戦略・SWOT・財務分析
    Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Microbion Corp-製薬・医療分野:企業M&A・提携分析
    Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company which develops therapeutic products. The company develops products for the treatment of antibiotic-resistant infections and control of microbial biofilms. It develops environmentally responsible solutions to prevent mic …
  • ITOCHU Corporation:企業のM&A・事業提携・投資動向
    ITOCHU Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITOCHU Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Emerson Electric Co.:戦略・SWOT・企業財務分析
    Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report Summary Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Samsung Engineering Co Ltd (028050):企業の財務・戦略的SWOT分析
    Samsung Engineering Co Ltd (028050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bio2 Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bio2 Medical Inc (Bio2 Medical) is a medical device company that develops vascular devices. The company’s products include angel catheter, an inferior vena cava filter for pulmonary embolism protection and access to the central venous system in critically ill patients. Its device is designed …
  • Biogen Inc (BIIB)-医療機器分野:企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Guardian Industries Corp:企業の戦略的SWOT分析
    Guardian Industries Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Oglethorpe Power Corporation:企業の発電所・SWOT分析2018
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆